• Verification code
  • Optimal Prices
    Buying products on this site guarantees the best price
  • Flexible Batches
    Flexible batch size to meet different needs of global customers
  • Prompt Delivery
    Warehouses in multiple cities to ensure timely delivery
  • Quality Assurance
    Strict process parameter control to ensure product quality
  • One-to-one Customization
    One-to-one custom synthesis for special structural needs

Prasugrel-[d3]

General Information
Catalog: BLP-009680
CAS: 1127253-02-4
Molecular Formula: C20H17D3FNO3S
Molecular Weight: 376.46
Chemical Structure
Prasugrel-[d3]
Description One of the isotopic labelled form of (±)-Prasugrel, which is a P2Y12(ADP receptor) inhibitor.
Synonyms (±)-Prasugrel-d3 (acetate-d3); (RS)-5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridinin-2-yl Acetate
Related CAS 150322-43-3 (unlabelled)
Purity 95% by HPLC; 98% atom D

Prasugrel-[d3], a labeled variant of the potent antiplatelet agent Prasugrel, finds diverse scientific and therapeutic applications. Here are the key applications of Prasugrel-[d3]:

Pharmacokinetic Studies: In the realm of pharmacokinetic exploration, Prasugrel-[d3] plays a pivotal role. Employed in investigating the absorption, distribution, metabolism, and excretion (ADME) of Prasugrel within the body, this deuterated derivative enables precise tracking of the drug’s trajectory and quantification of its presence in biological specimens. This detailed analysis enhances comprehension of the drug’s behavior, facilitating the optimization of dosage regimens for improved therapeutic outcomes.

Clinical Research: Within clinical domains, Prasugrel-[d3] emerges as a valuable tool for probing drug interactions, particularly with other antiplatelet agents or medications impacting its efficacy. Through in-depth examinations of how Prasugrel-[d3] interacts with diverse substances, healthcare providers gain insights crucial for adept therapy management and attenuation of potential adverse reactions. This meticulous approach ensures safer and more efficacious utilization of Prasugrel in patient care settings.

Biomarker Development: Prasugrel-[d3] assumes a key role in the realm of biomarker discovery and validation concerning platelet activity and antiplatelet therapy monitoring. By integrating this isotopically labeled compound into investigative endeavors, researchers can pinpoint specific biomarkers indicative of the efficacy of antiplatelet interventions. This emphasis on precision contributes to the advancement of personalized medicine strategies, thereby elevating the standard of care for patients requiring antiplatelet therapy.

Analytical Method Development: Within the domain of analytical chemistry, Prasugrel-[d3] stands as a cornerstone for the formulation and validation of methodologies targeting the detection and quantification of Prasugrel and its metabolites. Leveraging sophisticated techniques like mass spectrometry, analytical chemists establish robust protocols for accurate measurement of drug concentrations. These methodologies serve dual purposes, facilitating precise clinical diagnostics and ensuring stringent quality control across pharmaceutical manufacturing processes.

Interested in our Service & Products?
Need detailed information?

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2024 BOC Sciences. All Rights Reserved.
Inquiry Basket